Tobramycin Inhalation Powder Is Effective and Safe in the Treatment of Chronic Pulmonary Pseudomonas aeruginosa (Pa) Infection in Patients with Cystic Fibrosis

被引：0
|
作者：
Konstan, M. W. [1 ]
Geller, D. E. [2 ]
Brockhaus, F. [3 ]
Zhang, J. [3 ]
Angyalosi, G. [3 ]
机构：
[1] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA
[2] Nemours Childrens Clin, Orlando, FL USA
[3] Novartis, Basel, Switzerland
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1186
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [21] Tobramycin Inhalation Powder for P. aeruginosa Infection in Cystic Fibrosis: The EVOLVE Trial
    Konstan, Michael W.
    Geller, David E.
    Minic, Predrag
    Brockhaus, Florian
    Zhang, Jie
    Angyalosi, Gerhild
    PEDIATRIC PULMONOLOGY, 2011, 46 (03) : 230 - 238
  • [22] EASE OF USE OF TOBRAMYCIN INHALATION POWDER COMPARED WITH NEBULIZED TOBRAMYCIN AND COLISTIMETHATE SODIUM: A PHASE IV CROSSOVER STUDY IN CYSTIC FIBROSIS PATIENTS WITH PSEUDOMONAS AERUGINOSA INFECTION
    Greenwood, J.
    Schwarz, C.
    Sommerwerck, U.
    Nash, E. F.
    Tamm, M.
    Cao, W.
    Mastoridis, P.
    DeBonnett, L.
    Hamed, K.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 361 - 361
  • [23] Tobramycin Inhalation Powder Is As Effective As Tobramycin Inhalation Solution In Patients With Cystic Fibrosis: A Subgroup Analysis Of The Eager Trial
    Konstan, M. W.
    Parkins, M.
    Angyalosi, G.
    Higgins, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [24] Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis and Pseudomonas aeruginosa infection
    Quittner, AL
    Buu, A
    PEDIATRIC PULMONOLOGY, 2002, 33 (04) : 269 - 276
  • [25] Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis
    Assael, Baroukh Maurice
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (11) : 967 - 973
  • [26] A randomised comparison of two tobramycin formulations in cystic fibrosis (CF) patients with chronic pseudomonas aeruginosa (PA) infection for pharmacokinetic and therapeutic equivalence
    Sands, Dorota
    Sapiejka, Ewa
    Mazurek, Henryk
    Gaszczyk, Grzegorz
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [27] Pilot trial of tobramycin inhalation powder in cystic fibrosis patients with chronic Burkholderia cepacia complex infection
    Waters, Valerie
    Yau, Yvonne
    Beaudoin, Trevor
    Wettlaufer, Jillian
    Tom, Sean Kevin
    McDonald, Nancy
    Rizvi, Leena
    Klingel, Michelle
    Ratjen, Felix
    Tullis, Elizabeth
    JOURNAL OF CYSTIC FIBROSIS, 2017, 16 (04) : 492 - 495
  • [28] Antimicrobial treatment of pulmonary colonization and infection by Pseudomonas aeruginosa in cystic fibrosis patients
    Denton, M
    Wilcox, MH
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (04) : 468 - 474
  • [29] PILOT TRIAL OF TOBRAMYCIN INHALATION POWDER IN CYSTIC FIBROSIS PATIENTS WITH CHRONIC BURKHOLDERIA CEPACIA COMPLEX INFECTION
    Waters, V. J.
    Yau, Y.
    Ratjen, F.
    Tullis, E.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 319 - 319
  • [30] Budget Impact Model of Adding Tobramycin Inhalation Solution for Treatment of Pseudomonas aeruginosa in Cystic Fibrosis Patients.
    Woodward, T. C.
    Sacco, P.
    Brown, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
12345